Wayfinder Biosciences, a biotechnology company targeting RNA with small molecules, announced today a collaboration with Daiichi Sankyo focused on a key neurodegeneration target.

Vitamin D deficiency directly causes erectile dysfunction by increasing superoxide and reducing protective SLPI levels, as ...

A major new initiative, launched on 15 April, will map how gene activity shapes the immune system, and could help identify new therapeutic targets for conditions such as Inflammatory Bowel Disease ...

Researchers discover that inflammation and aging contribute to non-viral liver cancer development. Green tea's role in reversing some of the pathway dysregulation that may contribute to the cancer ...

Three Johns Hopkins experts discuss the potential of mRNA-powered therapeutics to produce lifesaving treatments and cures for a range of diseases, and why federal research cuts risk undermining U.S. s ...

Besides communicable diseases, vaccines can also help prevent or reduce the severity of non-communicable diseases like cancer ...

New research out of central Ohio is shedding light on preeclampsia – a dangerous form of high blood pressure during pregnancy ...

Hebrew University researchers say their innovative test can find tRNA fragments unique to the neurodegenerative disease ...

Remix Therapeutics (Remix), a clinical-stage biotechnology company developing small molecule therapies to modulate RNA processing and address the underlying drivers of disease, today announced the ...

Day 1 of the Ocala Breeders' Sales Spring 2-Year-Olds in Training Sale saw a decline in the gross, average and median. A ...

Oxford Nanopore Technologies, which develops and sells nanopore sequencing products, has announced the expansion of its Compatible Products Programme. These products are used for DNA or RNA sequencing ...

ChatGPT 4.1 is now rolling out, and it's a significant leap from GPT 4o, but it fails to beat the benchmark set by Google's ...